Champions Oncology Files 8-K on Financials
Ticker: CSBR · Form: 8-K · Filed: Mar 12, 2024 · CIK: 771856
| Field | Detail |
|---|---|
| Company | Champions Oncology, INC. (CSBR) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
TL;DR
Champions Oncology dropped an 8-K detailing its financial results. Check it out.
AI Summary
Champions Oncology, Inc. filed an 8-K on March 12, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's fiscal year ending on April 30th. Champions Oncology, Inc. is incorporated in Delaware and operates in the Biological Products sector.
Why It Matters
This 8-K filing provides an update on Champions Oncology's financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any significant new risks or adverse events.
Key Numbers
- 0430 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
Key Players & Entities
- CHAMPIONS ONCOLOGY, INC. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- March 12, 2024 (date) — Date of Report
- BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) (industry) — Standard Industrial Classification
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is dated March 12, 2024.
What is the Standard Industrial Classification for Champions Oncology, Inc.?
The SIC code is 2836, categorized under BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
In which state is Champions Oncology, Inc. incorporated?
Champions Oncology, Inc. is incorporated in Delaware.
What is the business address of Champions Oncology, Inc.?
The business address is 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD 21205.
Filing Stats: 463 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-03-12 16:31:43
Filing Documents
- csbr-20240312.htm (8-K) — 32KB
- csbr8-k1312024ex991xq324.htm (EX-99.1) — 155KB
- logobranding_headerleftali.jpg (GRAPHIC) — 31KB
- 0001628280-24-010569.txt ( ) — 362KB
- csbr-20240312.xsd (EX-101.SCH) — 2KB
- csbr-20240312_def.xml (EX-101.DEF) — 3KB
- csbr-20240312_lab.xml (EX-101.LAB) — 21KB
- csbr-20240312_pre.xml (EX-101.PRE) — 12KB
- csbr-20240312_htm.xml (XML) — 2KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On March 12, 2024, Champions Oncology, Inc. (the "Company") issued a press release regarding the Company's unaudited financial results for its third quarter ended January 31, 2024. A copy of the Company's press release is attached hereto as Exhibit 99.1. The information contained under Item 2.02 in this Current Report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibit is filed herewith: Exhibit No. 99.1 Press Release dated March 12, 202 4
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CHAMPIONS ONCOLOGY, INC. (Registrant) Date: March 12, 2024 By: /s/ Ronnie Morris Ronnie Morris Chief Executive Officer